GE’s 3D mammography device gets FDA approval

(Reuters) – General Electric Co’s healthcare unit last week won U.S. Food and Drug Administration approval for its mammography device that produces three-dimensional images to detect breast cancer. According to the company’s website, the device, SenoClaire, uses imaging technology that combines low radiation-dosed X-rays from multiple angles to produce a superior mammogram. The device consists of hardware and software upgrades to the company’s previously launched Senographe Essential 2D full-field digital mammography system. …
Go to Source